Kaye Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546K | Buy |
701
+5
| +0.7% | +$3.9K | 0.21% | 31 |
|
|
2025
Q1 | $575K | Buy |
696
+1
| +0.1% | +$826 | 0.23% | 31 |
|
|
2024
Q4 | $536K | Buy |
695
+1
| +0.1% | +$772 | 0.24% | 26 |
|
|
2024
Q3 | $615K | Buy |
694
+1
| +0.1% | +$886 | 0.25% | 27 |
|
|
2024
Q2 | $627K | Buy |
693
+3
| +0.4% | +$2.72K | 0.26% | 26 |
|
|
2024
Q1 | $536K | Buy |
690
+2
| +0.3% | +$1.56K | 0.23% | 25 |
|
|
2023
Q4 | $434K | Buy |
688
+1
| +0.1% | +$630 | 0.19% | 27 |
|
|
2023
Q3 | $369K | Buy |
687
+1
| +0.1% | +$537 | 0.17% | 28 |
|
|
2023
Q2 | $322K | Sell |
686
-52
| -7% | -$24.4K | 0.16% | 26 |
|
|
2023
Q1 | $253K | Buy |
738
+3
| +0.4% | +$1.03K | 0.13% | 29 |
|
|
2022
Q4 | $269K | Buy |
+735
| New | +$269K | 0.14% | 26 |
|